News

Parasitic worms reveal new insights into the evolution of sex and sex chromosomes

Valneva Announces Settlement Agreement with the UK Government

Gewessler/Kocher: Acht COMET-Zentren für Österreich genehmigt

Narbenlunge: Forschung gegen krankhafte Bindegewebsvermehrung in der Lunge

MedAustron Vorreiter für Softwaresysteme zur Behandlung

Umfrage belegt: Gutes Zeugnis für Biosimilars von Fachärzten in Österreich

Valneva Provides Update on European Inactivated, Whole-Virus COVID-19 Vaccine Program VLA2001

Lithoz announces the CeraMax Vario V900 3D printer with all-new LIS technology for large ceramic parts in full densities

Wandernde Atome: Erstmals Roaming bei Biomolekül beobachtet

Innovation Award: 1st place for new Kenevo

Cerion® 3D printing system wins innovation award

Valneva to Present on its Single-Shot Chikungunya Vaccine Candidate, Host Symposium at NECTM8

Valneva Joins Euronext’s Tech Leaders Index

Europäische Leitlinien „made in Tyrol“ für häufigste Erbkrankheit

Weiss-Forschungspreis: Neue Erkenntnisse in der Frühgeborenen-Forschung

Valneva to Present and Hold Investor Meetings at the Jefferies US Healthcare Conference

Preclinical Data on Novel Arenaviral HIV Therapeutic Vaccines Presented at Keystone Symposium

HOOKIPA announces positive Phase 1 data and Phase 2 plans for HB-200 program for the treatment of advanced head and neck cancers at ASCO

Gezielte Mikroernährung lindert Symptome bei Allergien

Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders